Broad genomic testing linked to longer survival in advanced lung cancer, according to new study
New research in the November 2026 issue of Journal of the National Comprehensive Cancer Network found that patients with advanced non-small cell lung cancer (NSCLC) lived longer when they received broad-based genomic sequencing (BGS)—testing a large panel of dozens or hundreds of genes at once—befor
<p>New research in the November 2026 issue of Journal of the National Comprehensive Cancer Network found that patients with advanced non-small cell lung cancer (NSCLC) lived longer when they received broad-based genomic sequencing (BGS)—testing a large panel of dozens or hundreds of genes at once—befor</p>